Autologous stem cell transplantation in multiple myeloma patients : utilization patterns and hospital effects
Evidence on volume outcome associations for autologous stem cell transplantation (ASCT) in multiple myeloma (MM) is limited. We investigated ASCT utilization patterns and volume outcome associations in the German National Registry for Stem Cell Transplants (DRST). MM patients with an upfront ASCT between 1998 and 2014 registered in the DRST were included. ASCT utilization increased strongly from 6% to 17% between 1999 and 2013 with the largest increase for patients aged 60-64 years (8-34%). The mean number of ASCTs conducted in the hospitals per year varied (quintiles, Q1:0.0-8.2 to Q5:31.0-102.7). Center volume was not associated with survival after upfront ASCT (lowest vs. highest center volume, hazard ratios and 95% confidence intervals: 0.95 (0.76-1.18), p = 0.92). Our findings may reflect a high standard of care and degree of specialization of centers performing ASCT for MM in Germany.
| Medienart: |
E-Artikel |
|---|
| Erscheinungsjahr: |
2020 |
|---|---|
| Erschienen: |
2020 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:61 |
|---|---|
| Enthalten in: |
Leukemia & lymphoma - 61(2020), 10 vom: 16. Okt., Seite 2365-2374 |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Jansen, Lina [VerfasserIn] |
|---|
| Links: |
|---|
| Themen: |
Journal Article |
|---|
| Anmerkungen: |
Date Completed 27.04.2021 Date Revised 27.04.2021 published: Print-Electronic Citation Status MEDLINE |
|---|
| doi: |
10.1080/10428194.2020.1768383 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
NLM310569710 |
|---|
| LEADER | 01000naa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM310569710 | ||
| 003 | DE-627 | ||
| 005 | 20231225140401.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 231225s2020 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1080/10428194.2020.1768383 |2 doi | |
| 028 | 5 | 2 | |a pubmed24n1035.xml |
| 035 | |a (DE-627)NLM310569710 | ||
| 035 | |a (NLM)32476543 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 1 | |a Jansen, Lina |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Autologous stem cell transplantation in multiple myeloma patients |b utilization patterns and hospital effects |
| 264 | 1 | |c 2020 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ƒaComputermedien |b c |2 rdamedia | ||
| 338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Date Completed 27.04.2021 | ||
| 500 | |a Date Revised 27.04.2021 | ||
| 500 | |a published: Print-Electronic | ||
| 500 | |a Citation Status MEDLINE | ||
| 520 | |a Evidence on volume outcome associations for autologous stem cell transplantation (ASCT) in multiple myeloma (MM) is limited. We investigated ASCT utilization patterns and volume outcome associations in the German National Registry for Stem Cell Transplants (DRST). MM patients with an upfront ASCT between 1998 and 2014 registered in the DRST were included. ASCT utilization increased strongly from 6% to 17% between 1999 and 2013 with the largest increase for patients aged 60-64 years (8-34%). The mean number of ASCTs conducted in the hospitals per year varied (quintiles, Q1:0.0-8.2 to Q5:31.0-102.7). Center volume was not associated with survival after upfront ASCT (lowest vs. highest center volume, hazard ratios and 95% confidence intervals: 0.95 (0.76-1.18), p = 0.92). Our findings may reflect a high standard of care and degree of specialization of centers performing ASCT for MM in Germany | ||
| 650 | 4 | |a Journal Article | |
| 650 | 4 | |a Research Support, Non-U.S. Gov't | |
| 650 | 4 | |a Transplantation | |
| 650 | 4 | |a multiple myeloma | |
| 650 | 4 | |a survival | |
| 650 | 4 | |a utilization patterns | |
| 650 | 4 | |a volume-outcome relationship | |
| 700 | 1 | |a Merz, Maximilian |e verfasserin |4 aut | |
| 700 | 1 | |a Engelhardt, Monika |e verfasserin |4 aut | |
| 700 | 1 | |a Weisel, Katja |e verfasserin |4 aut | |
| 700 | 1 | |a Scheid, Christof |e verfasserin |4 aut | |
| 700 | 1 | |a Straka, Christian |e verfasserin |4 aut | |
| 700 | 1 | |a Langer, Christian |e verfasserin |4 aut | |
| 700 | 1 | |a Salwender, Hans |e verfasserin |4 aut | |
| 700 | 1 | |a Einsele, Hermann |e verfasserin |4 aut | |
| 700 | 1 | |a Kröger, Nikolaus |e verfasserin |4 aut | |
| 700 | 1 | |a Beelen, Dietrich W |e verfasserin |4 aut | |
| 700 | 1 | |a Dreger, Peter |e verfasserin |4 aut | |
| 700 | 1 | |a Goldschmidt, Hartmut |e verfasserin |4 aut | |
| 700 | 1 | |a Brenner, Hermann |e verfasserin |4 aut | |
| 700 | 0 | |a German National Registry for Stem Cell Transplants (DRST) |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Leukemia & lymphoma |d 1989 |g 61(2020), 10 vom: 16. Okt., Seite 2365-2374 |w (DE-627)NLM012624047 |x 1029-2403 |7 nnns |
| 773 | 1 | 8 | |g volume:61 |g year:2020 |g number:10 |g day:16 |g month:10 |g pages:2365-2374 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.1080/10428194.2020.1768383 |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |d 61 |j 2020 |e 10 |b 16 |c 10 |h 2365-2374 | ||